» Articles » PMID: 8161287

Cannabis Abuse and the Course of Recent-onset Schizophrenic Disorders

Overview
Specialty Psychiatry
Date 1994 Apr 1
PMID 8161287
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We sought to examine the relation between cannabis abuse and the symptomatic course of recent-onset schizophrenia and related disorders.

Design: A prospective cohort study over a year using monthly Brief Psychiatric Rating Scale assessments.

Participants: Cannabis-abusing patients (n = 24) were compared with nonabusers (n = 69). Eleven patients were mild and 13 were heavy cannabis-abusing patients.

Results: Significantly more and earlier psychotic relapses occurred in the cannabis-abusing group (P = .03). This association became stronger when mild and heavy cannabis abuse were distinguished (P = .002). No confounding effect of other variables, eg, other street drugs, was found. In all but one patient, cannabis abuse preceded the onset of the first psychotic symptoms for at least 1 year.

Conclusions: Cannabis abuse and particularly heavy abuse can be considered a stressor eliciting relapse in patients with schizophrenia and related disorders and possibly a premorbid precipitant.

Citing Articles

International perspectives on physician knowledge, attitudes, and practices related to medical cannabis.

Syed S, Singh J, Elkholy H, Rojnic Palavra I, Tomicevic M, Eric A Front Public Health. 2025; 13:1463871.

PMID: 40051509 PMC: 11882600. DOI: 10.3389/fpubh.2025.1463871.


Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study.

Levi L, Bar-Haim M, Rossum I, Davidson M, Leucht S, Fleischhacker W Schizophr Bull. 2023; 49(4):903-913.

PMID: 36999551 PMC: 10318873. DOI: 10.1093/schbul/sbad033.


Cannabis use during the early COVID-19 pandemic: Use patterns, predictors, and subjective experiences.

Mielau J, Reiche S, Moon D, Gross E, Gutwinski S, Betzler F Front Psychiatry. 2023; 13:1037451.

PMID: 36704748 PMC: 9872100. DOI: 10.3389/fpsyt.2022.1037451.


Gut-microbiota-brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence.

Wan X, Eguchi A, Qu Y, Yang Y, Chang L, Shan J Eur Arch Psychiatry Clin Neurosci. 2022; 272(7):1297-1309.

PMID: 35666299 DOI: 10.1007/s00406-022-01437-1.


L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation.

Kopustinskiene D, Masteikova R, Lazauskas R, Bernatoniene J Antioxidants (Basel). 2022; 11(4).

PMID: 35453344 PMC: 9030479. DOI: 10.3390/antiox11040660.